| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 16.812 | 22.864 | 29.074 | 31.450 | 34.124 | 32.428 | 28.601 | 31.035 | 34.189 | 18.373 |
| Total Income - EUR | 16.813 | 22.864 | 29.074 | 31.450 | 34.124 | 32.428 | 28.601 | 31.035 | 34.189 | 18.441 |
| Total Expenses - EUR | 8.161 | 10.800 | 14.774 | 12.546 | 18.620 | 16.054 | 19.525 | 23.082 | 30.875 | 18.116 |
| Gross Profit/Loss - EUR | 8.652 | 12.064 | 14.300 | 18.904 | 15.504 | 16.374 | 9.076 | 7.953 | 3.314 | 325 |
| Net Profit/Loss - EUR | 8.147 | 11.378 | 13.428 | 17.960 | 14.481 | 15.470 | 8.235 | 7.022 | 2.885 | 247 |
| Employees | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Check the financial reports for the company - Ceprochem Line Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 180 | 682 | 518 | 1.506 | 1.088 | 789 | 499 | 228 | 727 | 896 |
| Current Assets | 14.648 | 17.068 | 19.783 | 21.559 | 24.101 | 22.192 | 11.655 | 10.435 | 5.085 | 5.686 |
| Inventories | 1.745 | 1.402 | 2.704 | 1.737 | 1.728 | 1.752 | 2.219 | 2.400 | 1.512 | 1.956 |
| Receivables | 3.055 | 5.121 | 12.265 | 16.428 | 18.821 | 15.190 | 2.909 | 3.111 | 2.495 | 2.568 |
| Cash | 9.849 | 10.545 | 4.814 | 3.393 | 3.552 | 5.250 | 6.526 | 4.924 | 1.078 | 1.162 |
| Shareholders Funds | 8.192 | 11.422 | 13.471 | 18.003 | 14.523 | 15.511 | 8.276 | 7.063 | 5.091 | 5.183 |
| Social Capital | 45 | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | 6.636 | 6.328 | 6.830 | 5.061 | 10.666 | 7.470 | 3.878 | 3.600 | 720 | 1.399 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "2059 - 2059" | |||||||||
| CAEN Financial Year |
2059
|
|||||||||
Comments - Ceprochem Line Srl